Objective
MilliDrop pioneering millifluidic technology to study microbes will massively advance the fields of microbiology worth €7bn worldwide. Manipulation of microbial cell culture in only one droplet (~100nl), together with automation and extraordinary parallelisation (1000 samples), stands to deliver new products for medicine and biotechnology. It will close the gap from lab to market and revolutionize the microbiology analysis after hundreds of years of standard Petri dishes technology.
The MilliDrop Analyzer is a unique, miniaturized and fully automated instrument for microorganisms’ fast culture and analysis. Each microorganism is grown in one droplet in a capillary containing several thousand droplets separated by air bubbles. Each droplet is monitored and measured in real time, enabling identification of infectious stains much faster than other existing technologies (6h vs 24h). Followed by immediate antibiotic susceptibility testing (AST) in the same instrument, it allows to obtain AST result in less than 12h after receiving the patient sample, instead of standard 48h. It opens extraordinary opportunities in clinical diagnostics enabling earlier and more precise diagnosis of infectious disease, giving a possibility to select and dose specific antibiotic early enough. It will reduce therapeutic failures by 60% and helping to combat antibiotic resistance which is a highly growing European and worldwide health challenge.
The proposed SME Instrument objective is to develop, validate and industrialize a new version of Medical Device Analyzer for in vitro diagnostic (IVD) clinical microbiology market. The first generation dedicated to the research and development market is already in the industrialization process. IVD version will be launched in 2020 and will enable the company to become European champion and to fast track its business to €11.8M and 60 job creation in 2023.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine surgery
- medical and health sciences health sciences infectious diseases
- medical and health sciences clinical medicine clinical microbiology
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs antibiotics
- medical and health sciences basic medicine pharmacology and pharmacy drug resistance antibiotic resistance
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.1.4. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-SMEInst-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
94160 SAINT-MANDE
France
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.